Advertisement

AIDS and Behavior

, Volume 20, Issue 4, pp 754–762 | Cite as

Condoms, Lubricants and Rectal Cleansing: Practices Associated with Heterosexual Penile-Anal Intercourse Amongst Participants in an HIV Prevention Trial in South Africa, Uganda and Zimbabwe

  • Zoe Duby
  • Miriam Hartmann
  • Elizabeth T. Montgomery
  • Christopher J. Colvin
  • Barbara Mensch
  • Ariane van der Straten
Original Paper

Abstract

We investigated condom and lubricant use, rectal cleansing and rectal gel use for penile-anal intercourse (PAI), during in-depth interviews with women from South Africa, Uganda and Zimbabwe who formerly participated in VOICE, a five-arm HIV prevention trial of two antiretroviral tablets and a vaginal gel. Few studies have addressed practices related to PAI among women; existing data from Africa on condom and lubricant use for PAI, as well as preparatory practices of PAI such as rectal cleansing, are limited to men who have sex with men. Women demonstrated a lack of awareness of HIV transmission risks of PAI and none of the participants reported using condom-compatible lubricants for PAI. Participants described a variety of preparatory rectal cleansing practices. Some participants disclosed rectal use of the vaginal study gel. Understanding practices related to PAI in Africa is critical to microbicide development, as these practices are likely to influence the acceptability, feasibility, and use of both vaginal and rectal microbicide products.

Keywords

Condom Lubricant Rectal cleansing Heterosexual Anal intercourse HIV 

Notes

Acknowledgments

We would like to acknowledge the women who participated in this study. The full MTN-003D study team can be viewed at http://www.mtnstopshiv.org/studies/4493. The study was designed and implemented by the Microbicide Trials Network (MTN). The MTN is funded by the National Institute of Allergy and Infectious Diseases (UM1AI068633, UM1AI068615, UM1AI106707), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the U.S. National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

References

  1. 1.
    Karim SS, Ramjee G, American Public Health Association. Anal sex and HIV transmission in women. Am J Public Health. 1998;88(8):1265–6.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Halperin DT. Heterosexual anal intercourse: prevalence, cultural factors, and HIV infection and other health risks, Part I. AIDS Patient Care STDs. 1999;13(12):717–30.CrossRefPubMedGoogle Scholar
  3. 3.
    Kalichman SC, Simbayi LC, Cain D, Jooste S. Heterosexual anal intercourse among community and clinical settings in Cape Town, South Africa. Sex Transm Infect. 2009;85(6):411–5.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Priddy FH, Wakasiaka S, Hoang TD, Smith DJ, Farah B, del Rio C, et al. Anal sex, vaginal practices, and HIV incidence in female sex workers in urban Kenya: implications for the development of intravaginal HIV prevention methods. AIDS Res Hum Retrovir. 2011;27(10):1067–72.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Exner TM, Correale J, Carballo-Dieguez A, Salomon L, Morrow KM, Dolezal C, et al. Women’s anal sex practices: Implications for formulation and promotion of a rectal microbicide. AIDS Educ Prevent. 2008;20(2):148–59.CrossRefGoogle Scholar
  6. 6.
    McGowan I, Taylor DJ. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies. Sex Transm Dis. 2010;37(6):361–4.PubMedGoogle Scholar
  7. 7.
    Mensch BS, Hewett PC, Abbott S, Rankin J, Littlefield S, Ahmed K, et al. Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel. AIDS Behav. 2010;15(2):407–21.CrossRefGoogle Scholar
  8. 8.
    Mâsse BR, Boily M-C, Dimitrov D, Desai K. Efficacy dilution in randomized placebo-controlled vaginal microbicide trials. Emerg Themes Epidemiol. 2009;6(1):5.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    McGowan I. The Clinical Development of Rectal Microbicides for HIV Prevention. Doctoral thesis. University of Liverpool, Liverpool; 2013.Google Scholar
  10. 10.
    Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol. 2010;39(4):1048–63.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    McBride KR, Fortenberry JD. Heterosexual anal sexuality and anal sex behaviors: a review. J Sex Res. 2010;47(2–3):123–36.CrossRefPubMedGoogle Scholar
  12. 12.
    Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002;29(1):38–43.CrossRefPubMedGoogle Scholar
  13. 13.
    Carballo-Diéguez A, Bauermeister JA, Ventuneac A, Dolezal C, Balan I, Remien RH. The use of rectal douches among HIV-uninfected and infected men who have unprotected receptive anal intercourse: implications for rectal microbicides. AIDS Behav. 2008;12(6):860–6.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Fuchs EJ, Lee LA, Torbenson MS, Parsons TL, Bakshi RP, Guidos AM, et al. Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis. 2007;195(5):703–10.CrossRefPubMedGoogle Scholar
  15. 15.
    Javanbakht M, Stahlman S, Pickett J, LeBlanc M-A, Gorbach PM. Prevalence and types of rectal douches used for anal intercourse: results from an international survey. BMC Infect Dis. 2014;14(1):95.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Koblin BA, Mayer K, Mwatha A, Brown-Peterside P, Holt R, Marmor M, et al. Douching practices among women at high risk of HIV infection in the United States: implications for microbicide testing and use. Sex Transm Dis. 2002;29(7):406–10.CrossRefPubMedGoogle Scholar
  17. 17.
    van der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B, et al. Women’s experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLoS ONE. 2014;9(2):e89118.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Duby Z, Colvin C. Conceptualizations of heterosexual anal sex and HIV risk in five east African communities. J Sex Res. 2014;51(8):863–73.CrossRefPubMedGoogle Scholar
  19. 19.
    Marston C, Lewis R. Anal heterosex among young people and implications for health promotion: a qualitative study in the UK. BMJ Open. 2014;4(8):e004996.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Stadler JJ, Delany S, Mntambo M. Sexual coercion and sexual desire: Ambivalent meanings of heterosexual anal sex in Soweto. South Africa. AIDS Care. 2007;19(10):1189–93.CrossRefPubMedGoogle Scholar
  21. 21.
    Maynard E, Carballo-Diéguez A, Ventuneac A, Exner T, Mayer K. Women’s experiences with anal sex: motivations and implications for STD prevention. Perspect Sex Reprod Health. 2009;41(3):142–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Houston AM, Fang J, Husman C, Peralta L. More than just vaginal intercourse: anal intercourse and condom use patterns in the context of “main” and ‘casual’ sexual relationships among urban minority adolescent females. J Pediatr Adolesc Gynecol. 2007;20(5):299–304.CrossRefPubMedGoogle Scholar
  23. 23.
    Alexander M, Mainkar M, Deshpande S, Chidrawar S, Sane S, Mehendale S. Heterosexual anal sex among female sex workers in high HIV prevalence states of India: need for comprehensive intervention. PLoS ONE. 2014;9(2):e88858.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Decker MR, Pearson E, Illangasekare SL, Clark E, Sherman SG. Violence against women in sex work and HIV risk implications differ qualitatively by perpetrator. BMC Public Health. 2013;13(1):1.CrossRefGoogle Scholar
  25. 25.
    Silverman BG, Gross TP. Use and effectiveness of condoms during anal intercourse: a review. Sex Transm Dis. 1997;24(1):11–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Geibel S. Condoms and condiments: compatibility and safety of personal lubricants and their use in Africa. J Int AIDS Soc. 2013;16:18531.CrossRefGoogle Scholar
  27. 27.
    Gorbach PM, Weiss RE, Fuchs E, Jeffries RA, Hezerah M, Brown S, et al. The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk. Sex Transm Dis. 2012;39(1):59.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Saethre EJ, Stadler J. Gelling medical knowledge: innovative pharmaceuticals, experience, and perceptions of efficacy. Anthropol Med. 2010;17(1):99–111.CrossRefPubMedGoogle Scholar
  29. 29.
    Peltzer K, Mngqundaniso N, Petros G. A controlled study of an HIV/AIDS/STI/TB intervention with traditional healers in KwaZulu-Natal. South Africa. AIDS Behav. 2006;10(6):683–90.CrossRefPubMedGoogle Scholar
  30. 30.
    Leyva FJ, Bakshi RP, Fuchs EJ, Li L, Caffo BS, Goldsmith AJ, et al. Isoosmolar enemas demonstrate preferential gastrointestinal distribution, safety, and acceptability compared with hyperosmolar and hypoosmolar enemas as a potential delivery vehicle for rectal microbicides. AIDS Res Hum Retrovir. 2013;29(11):1487–95.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Dezzutti CS, Shetler C, Mahalingam A, Ugaonkar SR, Gwozdz G, Buckheit KW, et al. Safety and efficacy of tenofovir/IQP-0528 combination gels: a dual compartment microbicide for HIV-1 prevention. Antivir Res. 2012;96(2):221–5.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Ham A, Lustig W, Nugent S, Peters J, Katz D, Shelter C, et al. Formulation development of the DuoGel: a dual chamber vaginal/rectal anti-HIV microbicide gel. In: American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, Abstr. R6132, 2013.Google Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Zoe Duby
    • 1
    • 2
    • 6
  • Miriam Hartmann
    • 3
  • Elizabeth T. Montgomery
    • 3
  • Christopher J. Colvin
    • 2
  • Barbara Mensch
    • 4
  • Ariane van der Straten
    • 3
    • 5
  1. 1.Department of MedicineDesmond Tutu HIV Centre, University of Cape TownCape TownSouth Africa
  2. 2.School of Public Health & Family MedicineUniversity of Cape TownCape TownSouth Africa
  3. 3.Women’s Global Health ImperativeRTI InternationalSan FranciscoUSA
  4. 4.Population CouncilNew YorkUSA
  5. 5.University of California, San FranciscoSan FranciscoUSA
  6. 6.Faculty of Health SciencesUniversity of Cape TownCape TownSouth Africa

Personalised recommendations